Model Patent Prosecution Templates
AIPLA's Patent Law Committee maintains a collection of sample documents related to day-to-day patent prosecution. These documents are exemplary and may not be ideal for every situation. Use them at your own risk.*
Member log-in required to access files.
Model Response Shells:
Each of these documents contains a comprehensive shell document that can be used to formulate a response to 35 U.S.C. 112, 102, 103, or 101 rejections made by a patent examiner during prosecution.
Model Appeal Brief: (Doc) (PDF)
This document contains the overall structure of appeal brief with a section for drafting responses to point out error in rejections made in 35 U.S.C. 112, 102, 103, 101, and obviousness-type double patenting rejections. The model appeal brief includes summaries of the relevant portions of the PTAB’s designated informative and precedential decisions applicable to ex parte appeals along with associated Federal Circuit case law.
Model Reply Brief: (Doc) (PDF)
This document contains the overall structure of a reply brief along with relevant case law summaries to use for handling new grounds of rejection in an Examiner’s Answer.
*Nothing included in these sample documents or elsewhere on this site should be considered legal advise on the part of AIPLA or any of its members.
Join us as our speakers discuss march-in rights and compulsory licenses. Recent events like governmental agencies turning to march-in as a potential means to lower drug pricing or the pandemic have refueled the discussion on compulsory licenses here and in Europe. Our speakers will review the history of the Bayh Dole act as well as compulsory licenses in Europe and provide an overview of recent developments in both jurisdictions. Finally, the speakers touch on the implications and concerns for patent holders and future innovation in the biopharma space here and in Europe.
Presented by:
Christine Kanz, Hoyng Rokh Monegier
Joanna Brougher, BioPharma Law Group, PLLC
This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. CLE is included for our All-Access Pass holders and Corporate Subscribers.
Pricing below only applies to those requesting CLE
Registration Type | AIPLA Member Rate | Non-Member Rate |
Individual Registration | $99 | $249 |
2-5 Attendees per Site | $249 | $399 |
6-10 Attendees per Site | $449 | $599 |
11-15 Attendees per Site | $649 | $799 |
16-20 Attendees per Site | $749 | $899 |
21+ Attendees per Site | $849 | $999 |
Special rate for AIPLA Solo Practitioner Members: $65
Special rate for AIPLA Student Members: $10
In response to Covid-19, AIPLA has put in-place a new process for Multiple Attendee Site registrations that allows each site registrant to participate in the webinar independently. Contact cle@aipla.org at least 3 business days prior to the live webinar for site registrations.
Paid Registration includes:
- CLE certification/processing for applicable states. Reference CLE Information below for complete details.
- Webinar materials, including complete CLE processing information, accessible 24-48 hours before webinar date.
Cancellation Policy:
To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product.
System requirements:
Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices. Check system compatibility here.
Accessibility for hearing impaired:
AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.
CLE INFORMATION
CLE is approved with the following states:
- Alaska
- California
- Missouri
- New Jersey (Under New Jersey's Reciprocity Rule)
- New York (Under New York's Approved Jurisdiction Policy)
- Pennsylvania
- Texas
- Vermont
AIPLA has applied for CLE accreditation in the following states:
- Florida
- Illinois
- Minnesota
- Ohio
- Tennessee
- Virginia
- Washington
For information on CLE accreditation in all other states, please contact our CLE Department at cle@aipla.org. CLE credit may be available, but will require additional time for approval and COA delivery.
CLE Restrictions:
ATTENTION attorneys in Louisiana, Ohio, Pennsylvania, and Utah
These states mandate attorneys can only view a webinar independently at their own computer to receive CLE credit. Multiple attendees prohibited.
ATTENTION attorneys in Alabama and Rhode Island
AIPLA does not submit courses for approval in Alabama or Rhode Island. Attendees needing credit in these states may select the free, no CLE option to watch the webinar and use course materials and their certificate of attendance to request course approval directly from the State Bars.
ATTENTION attorneys in Arizona
Arizona does not certify courses or providers. Arizona lawyers are required to independently review AZ's regulations and make their own determination that it qualifies for credit towards their MCLE requirements. MCLE Regulation 104(A) identifies the standards to apply. AIPLA will email an attendance affidavit to registrants requesting AZ CLE credit after the webinar.
ATTENTION attorneys in New Hampshire
New Hampshire attendees must self-determine whether a program is eligible for credit, and self-report their attendance according to NH Supreme Court Rule 53. The New Hampshire Minimum Continuing Legal Education (NHMCLE) Board does not approve or accredit CLE activities for the NH Minimum CLE requirement.
Disclaimer: AIPLA is a nonprofit national bar association. The sole purpose of this CLE program is to provide educational and informational content. AIPLA does not provide legal services or advice. The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors. These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.
Add to: